The interplay of effector and regulatory T cells in cancer

Rahul Roychoudhuri, Robert L. Eil, Nicholas P. Restifo

Research output: Contribution to journalReview articlepeer-review

103 Scopus citations


Regulatory T (Treg) cells suppress effector T (Teff) cells and prevent immune-mediated rejection of cancer. Much less appreciated are mechanisms by which Teff cells antagonize Treg cells. Herein, we consider how complex reciprocal interactions between Teff and Treg cells shape their population dynamics within tumors. Under states of tolerance, including during tumor escape, suppressed Teff cells support Treg cell populations through antigen-dependent provision of interleukin (IL)-2. During immune activation, Teff cells can lose this supportive capacity and directly antagonize Treg cell populations to neutralize their immunosuppressive function. While this latter state is rarely achieved spontaneously within tumors, we propose that therapeutic induction of immune activation has the potential to stably disrupt immunosuppressive population states resulting in durable cancer regression.

Original languageEnglish (US)
Pages (from-to)101-111
Number of pages11
JournalCurrent opinion in immunology
StatePublished - Apr 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'The interplay of effector and regulatory T cells in cancer'. Together they form a unique fingerprint.

Cite this